UnknownNot Applicable

Comparing the Efficacy of Steroid, Acupuncture and Platelet Rich Plasma Injection in Patients With Sciatica

Taiwan90 participantsStarted 2019-04-24

Plain-language summary

Disc herniation, stenosis of the spine and spondylolisthesis are the common causes of radiculitis in medical practice today, and can cause symptoms of sciatica. Steroid injection, acupuncture and platelet-rich plasma injection are often used interventions for the treatments of sciatica. The investigators will investigate the efficacy and safety of steroid injection, acupuncture and platelet-rich plasma injection for sciatica in this single center, parallel, randomized-controlled clinical trial.

Who can participate

Age range20 Years – 80 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion criteria

✓. Female or male, 20 to 80 years of age.
✓. Participants who had dermatome between L3 to S1, or participants whose straight leg raising test was positive, or participants had Meyerding Grade I to II spondylolisthesis or herniated intervertebral disc or spinal stenosis diagnosed by X-rays, Magnetic resonance imaging or computed tomography.
✓. Participants whose sciatica symptom doesn't have occur time limit.
✓. Participants who agreed to follow the trial protocol.
✓. Participants who could complete the study treatment and assessments.
✓. Participants who had steroid or pain control injection can participate the study after receiving injection more than 3 days.

Exclusion criteria

✕. Participants with severe progressive neurological symptoms (e.g. cauda equina compression).
✕. Participants who had undergone surgery for lumbar disc herniation within 6 months.
✕. Participants whose sciatica symptom wasn't caused by lumbar radiculopathy.
✕. Participants with cardiovascular, liver, kidney, or hematopoietic system diseases, severe psychiatric or psychological disorder, or cancer.
✕. Women who were pregnant.
✕. Participants with a pacemaker, metal allergy, or severe fear of needles.

What they're measuring

visual analogue scale score

Timeframe: 2 weeks

Trial details

NCT IDNCT03801512

SponsorTaipei Medical University Hospital

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2025-05-28

Contact for this trial

Meng-Huang Wu, PhD

886 2 27372181 141036@h.tmu.edu.tw

View on ClinicalTrials.gov More Sciatica trials